Luteolin as an adjuvant effectively enhances CTL anti-tumor response in B16F10 mouse model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Luteolin as an adjuvant effectively enhances CTL anti-tumor response in B16F10 mouse model
Authors
Keywords
Luteolin, Tumor vaccine, Adjuvant, Anti-tumor, Melanoma
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 94, Issue -, Pages 107441
Publisher
Elsevier BV
Online
2021-02-21
DOI
10.1016/j.intimp.2021.107441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
- (2020) Keitaro Iida et al. CANCER SCIENCE
- Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
- (2018) James Larkin et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner
- (2018) Sweta Ghosh et al. Oncotarget
- Activation of IRF3 contributes to IFN-γ and ISG54 expression during the immune responses to B16F10 tumor growth
- (2017) Zachary Guinn et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IL-12 induces autophagy in human breast cancer cells through AMPK and the PI3K/Akt pathway
- (2017) Yan Lin et al. Molecular Medicine Reports
- Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
- (2017) Masayuki Hayashi et al. EBioMedicine
- Signaling and Polarized Communication Across the T Cell Immunological Synapse
- (2016) Michael L. Dustin et al. Annual Review of Cell and Developmental Biology
- Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses
- (2016) Amir Dashti et al. CANCER LETTERS
- Molecular targets of luteolin in cancer
- (2016) Muobarak J. Tuorkey EUROPEAN JOURNAL OF CANCER PREVENTION
- Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response
- (2016) Guillaume Sarrabayrouse et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Metabolism in the Immunobiology of Regulatory T Cells
- (2016) Mario Galgani et al. JOURNAL OF IMMUNOLOGY
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
- (2016) Noha Abdel-Wahab et al. PLoS One
- The FDA Guidance on Therapeutic Cancer Vaccines: The Need for Revision to Include Preventive Cancer Vaccines or for a New Guidance Dedicated to Them
- (2015) O. J. Finn et al. Cancer Prevention Research
- Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
- (2015) Daniel Shouval et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Beneficial Effects of Nitric Oxide on Outcomes after Cardiac Arrest and Cardiopulmonary Resuscitation in Hypothermia-treated Mice
- (2014) Kotaro Kida et al. ANESTHESIOLOGY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse
- (2014) Kaushik Choudhuri et al. NATURE
- Laser vaccine adjuvants
- (2014) Satoshi Kashiwagi et al. Human Vaccines & Immunotherapeutics
- Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
- (2013) S. Kumari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model
- (2013) Hu Liu et al. Human Vaccines & Immunotherapeutics
- Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12-Primed CD8+ T Cells in a Melanoma Model
- (2011) D. N. Lisiero et al. JOURNAL OF IMMUNOLOGY
- Alum adjuvant: some of the tricks of the oldest adjuvant
- (2011) M. Kool et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient
- (2009) Rolf K. Swoboda et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now